NGM, J&J subsidiary in diabetes deal

NGM Biopharmaceuticals Inc. (South San Francisco, Calif.) partnered with Janssen Pharmaceuticals Inc. to discover and develop compounds that mimic the potential glucoregulatory effects of bariatric su...